Compile Data Set for Download or QSAR
Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 6821
TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152988BDBM152988(US8993614, 53)
Affinity DataIC50: 3.40nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152971BDBM152971(US8993614, 36 | BDBM152973)
Affinity DataIC50: 4.21nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152989BDBM152989(US8993614, 54)
Affinity DataIC50: 4.21nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152966BDBM152966(US8993614, 30)
Affinity DataIC50: 4.30nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152963BDBM152963(US8993614, 24)
Affinity DataIC50: 4.39nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152975BDBM152975(US8993614, 40)
Affinity DataIC50: 4.44nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152980BDBM152980(US8993614, 45 | BDBM152981 | BDBM152982)
Affinity DataIC50: 4.63nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152990BDBM152990(US8993614, 55)
Affinity DataIC50: 4.75nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152979BDBM152979(US8993614, 44)
Affinity DataIC50: 4.86nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152974BDBM152974(US8993614, 39)
Affinity DataIC50: 5.06nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152977BDBM152977(US8993614, 42 | BDBM152978)
Affinity DataIC50: 5.09nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152986BDBM152986(US8993614, 51)
Affinity DataIC50: 5.14nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152976BDBM152976(US8993614, 41)
Affinity DataIC50: 5.18nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152970BDBM152970(US8993614, 35)
Affinity DataIC50: 5.25nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152977BDBM152977(US8993614, 42 | BDBM152978)
Affinity DataIC50: 5.69nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152964BDBM152964(US8993614, 26)
Affinity DataIC50: 5.82nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152959BDBM152959(US8993614, 20)
Affinity DataIC50: 5.84nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152983BDBM152983(US8993614, 48)
Affinity DataIC50: 6.96nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152961BDBM152961(US8993614, 22)
Affinity DataIC50: 7.13nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152972BDBM152972(US8993614, 37)
Affinity DataIC50: 7.14nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152965BDBM152965(US8993614, 28)
Affinity DataIC50: 8.19nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152968BDBM152968(US8993614, 33)
Affinity DataIC50: 8.22nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152969BDBM152969(US8993614, 34)
Affinity DataIC50: 9.09nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152950BDBM152950(US8993614, 11A)
Affinity DataIC50: 10.1nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152944BDBM152944(US8993614, 5)
Affinity DataIC50: 10.4nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152941BDBM152941(US8993614, 2)
Affinity DataIC50: 10.8nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152962BDBM152962(US8993614, 23)
Affinity DataIC50: 11nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152956BDBM152956(US8993614, 17)
Affinity DataIC50: 11.7nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152953BDBM152953(US8993614, 14)
Affinity DataIC50: 12nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152954BDBM152954(US8993614, 15)
Affinity DataIC50: 12.8nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152957BDBM152957(US8993614, 18)
Affinity DataIC50: 13.1nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152955BDBM152955(US8993614, 16)
Affinity DataIC50: 13.4nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152952BDBM152952(US8993614, 13)
Affinity DataIC50: 14.2nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152945BDBM152945(US8993614, 6)
Affinity DataIC50: 14.5nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152942BDBM152942(US8993614, 3)
Affinity DataIC50: 16.3nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152943BDBM152943(US8993614, 4)
Affinity DataIC50: 18.7nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152991BDBM152991(US8993614, 11B)
Affinity DataIC50: 19.4nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152971BDBM152971(US8993614, 36 | BDBM152973)
Affinity DataIC50: 20.2nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152951BDBM152951(US8993614, 12)
Affinity DataIC50: 23.8nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152985BDBM152985(US8993614, 50)
Affinity DataIC50: 26.5nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152987BDBM152987(US8993614, 52)
Affinity DataIC50: 26.7nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152940BDBM152940(US8993614, 1)
Affinity DataIC50: 29.6nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152980BDBM152980(US8993614, 45 | BDBM152981 | BDBM152982)
Affinity DataIC50: 30.3nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152980BDBM152980(US8993614, 45 | BDBM152981 | BDBM152982)
Affinity DataIC50: 40.8nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152960BDBM152960(US8993614, 21)
Affinity DataIC50: 43.5nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152946BDBM152946(US8993614, 7)
Affinity DataIC50: 45nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152958BDBM152958(US8993614, 19)
Affinity DataIC50: 51.4nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152949BDBM152949(US8993614, 10)
Affinity DataIC50: 53.6nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152947BDBM152947(US8993614, 8)
Affinity DataIC50: 53.6nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 152984BDBM152984(US8993614, 49)
Affinity DataIC50: 80.1nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
US Patent

Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: